31
January

10:00 AM EST

IQVIA Decentralized Trials Boardroom: GCP and the Complexities remote clinicians bring to clinical research

Virtual Boardroom

What to expect

Timely information, interactive format

While in-home healthcare isn’t new, providing compassionate protocol-required care to patients in their homes is still a component of DCTs that we are understanding the best ways of utilizing these types of visits. Sites and trial participants have become familiar with decentralized study elements that enable a personalized patient-centric experience, but how do we ensure consumer interest translates into clinical research actions?

While remote trials offer participants a study experience on their terms, there are still times when trained professionals can be utilized to carry out protocol-specific tasks simplifying trial delivery, benefiting sponsors,sites, and patients. In this session, IQVIA Research Nursing and Phlebotomy Solutions invite you to discuss how mobile research physicians can fit into your trial and how DCT services address patient data privacy and regulatory compliance practices that are critical for continued success and global expansion.

Online Agenda

Why you should attend

We invite you to contribute your expertise to an exclusive boardroom discussion about clinical trial payments.

Meet Our Facilitator

Krista Bradley, MBA, RN

VP & General Manager – Research Nursing & Phlebotomy Solutions – Decentralized Trials IQVIA

Eric Neeley, PhD, PMP

Senior Director – Research Nursing & Phlebotomy Solutions IQVIA

Owen Corbin, JD CIPM

Sr. Director, DCT Regulatory and Data Privacy – IQVIA Decentralized Clinical Trials IQVIA

Eric Klaver

DCT Regulatory Director – IQVIA Decentralized Clinical Trials IQVIA

More about IQVIA

More information

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility—enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries. You can learn more: iqvia.com

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Clinical Trials IQVIA

IQVIA Virtual Boardroom – 26th April 2022

IQVIA Decentralized Trials Boardroom: GCP and the Complexities remote clinicians bring to clinical research

Virtual Boardroom

Timely information, interactive format

Online Agenda

Identify the driving forces of sites and participants that utilize remote clinicians or services, and challenges to adoption

Mindfully weave decentralized aspects into your trials that entice the participant, and also help conduct assessments outside of the site in compliance with protocol and regulatory requirements

Accelerate seamless data collection while empowering patients with greater choice and control over their trial experience

Why you should attend

Meet Our Facilitator

Krista Bradley, MBA, RN

Eric Neeley, PhD, PMP

Owen Corbin, JD CIPM

Eric Klaver

More about IQVIA

Further Information

Here To Help

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

Thrombosis

Rare Diseases

This is required field*

0-10

10-50

50-100

100-500

500+

This is required field*

Under £100,000

£100,000 - £500,000

£500,000 - £1,000,000

£1,000,000 - £5,000,000

£5,000,000 - £10,000,000

£10,000,000 +

This is required field*

Discovery to Development

Pre-Clinical

Phase 1

Phase 2

Phase 3